What is it about?
This study shows for the first time treatment of pediatric Asthmatic patients with IL-6 blockade through Tocilizumab, an IL-6R antibody. This approach shows a precision medicine approach based on genetic/mutation background of the patients
Featured Image
Why is it important?
This is the first time to show
Read the Original
This page is a summary of: Treatment of severe persistent asthma with IL-6 receptor blockade, The Journal of Allergy and Clinical Immunology In Practice, May 2019, Elsevier,
DOI: 10.1016/j.jaip.2019.02.043.
You can read the full text:
Contributors
The following have contributed to this page
